Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia

. 2015 May ; 47 (5) : 535-538. [epub] 20150325

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid25807284

Grantová podpora
GGP13082 Telethon - Italy
R01 HL120728 NHLBI NIH HHS - United States
U54 HL112311 NHLBI NIH HHS - United States
P30 CA046934 NCI NIH HHS - United States
K01 GM103806 NIGMS NIH HHS - United States
MOP-81208 Canadian Institutes of Health Research - Canada
UL1 TR001082 NCATS NIH HHS - United States
GM103806 NIGMS NIH HHS - United States
MOP-259952 Canadian Institutes of Health Research - Canada
HL112311 NHLBI NIH HHS - United States

Some familial platelet disorders are associated with predisposition to leukemia, myelodysplastic syndrome (MDS) or dyserythropoietic anemia. We identified a family with autosomal dominant thrombocytopenia, high erythrocyte mean corpuscular volume (MCV) and two occurrences of B cell-precursor acute lymphoblastic leukemia (ALL). Whole-exome sequencing identified a heterozygous single-nucleotide change in ETV6 (ets variant 6), c.641C>T, encoding a p.Pro214Leu substitution in the central domain, segregating with thrombocytopenia and elevated MCV. A screen of 23 families with similar phenotypes identified 2 with ETV6 mutations. One family also had a mutation encoding p.Pro214Leu and one individual with ALL. The other family had a c.1252A>G transition producing a p.Arg418Gly substitution in the DNA-binding domain, with alternative splicing and exon skipping. Functional characterization of these mutations showed aberrant cellular localization of mutant and endogenous ETV6, decreased transcriptional repression and altered megakaryocyte maturation. Our findings underscore a key role for ETV6 in platelet formation and leukemia predisposition.

Children's Hospital of Michigan Wayne State University Detroit MI USA

Department of Biochemistry and Molecular Genetics University of Colorado AMC Aurora Colorado USA

Department of Biochemistry University of Toronto Toronto Ontario Canada

Department of Internal Medicine Haematology Oncology University Hospital Brno

Department of Internal Medicine IRCCS Policlinico San Matteo Foundation University of Pavia Pavia Italy

Department of Internal Medicine University of Utah Salt Lake City Utah USA

Department of Medical Sciences University of Trieste Trieste Italy

Department of Medicine University of Toronto Division of Rheumatology University Health Network Toronto Western Hospital Toronto Ontario Canada

Department of Paediatrics Division of Haematology Oncology University of Toronto and The Hospital for Sick Children Toronto Ontario Canada

Department of Pathology University of Colorado AMC Aurora Colorado USA

Department of Pediatrics University of Colorado Anschutz Medical Campus Aurora Colorado CO USA

Departments of Medicine University of Colorado AMC Aurora Colorado USA

Human Medical Genetics and Genomics Program University of Colorado AMC Aurora Colorado USA

Institute for Maternal and Child Health IRCCS Burlo Garofolo Trieste Italy

Instituto de Investigaciones Medicas Alfredo Lanari Universidad de Buenos Aires Buenos Aires Argentina

Molecular Medicine Program University of Utah Salt Lake City Utah USA

Program in Cell Biology Research Institute The Hospital for Sick Children Toronto Ontario Canada

Komentář v

PubMed

Zobrazit více v PubMed

Song WJ, et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet. 1999;23:166–75. PubMed

Nichols KE, et al. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet. 2000;24:266–70. PubMed PMC

Kar A, Gutierrez-Hartmann A. Molecular mechanisms of ETS transcription factor-mediated tumorigenesis. Crit Rev Biochem Mol Biol. 2013;48:522–43. PubMed PMC

Romana SP, et al. Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21) Leukemia. 1996;10:167–70. PubMed

Patel N, et al. Expression profile of wild-type ETV6 in childhood acute leukaemia. Br J Haematol. 2003;122:94–8. PubMed

Barjesteh van Waalwijk van Doorn-Khosrovani S, et al. Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia. Oncogene. 2005;24:4129–37. PubMed

Bejar R, et al. Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med. 2011;364:2496–506. PubMed PMC

Van Vlierberghe P, et al. ETV6 mutations in early immature human T cell leukemias. J Exp Med. 2011;208:2571–9. PubMed PMC

Zhang MY, et al. Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy. Nat Genet. 2015;47:180–5. PubMed PMC

Rasighaemi P, Onnebo SM, Liongue C, Ward AC. ETV6 (TEL1) regulates embryonic hematopoiesis in zebrafish. Haematologica. 2014 PubMed PMC

Wang LC, et al. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J. 1997;16:4374–83. PubMed PMC

Wang LC, et al. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev. 1998;12:2392–402. PubMed PMC

Hock H, et al. Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival. Genes Dev. 2004;18:2336–41. PubMed PMC

Pereira CF, et al. Induction of a hemogenic program in mouse fibroblasts. Cell Stem Cell. 2013;13:205–18. PubMed PMC

Orkin SH, et al. Abnormal RNA processing due to the exon mutation of beta E-globin gene. Nature. 1982;300:768–9. PubMed

Green SM, Coyne HJ, 3rd, McIntosh LP, Graves BJ. DNA binding by the ETS protein TEL (ETV6) is regulated by autoinhibition and self-association. J Biol Chem. 2010;285:18496–504. PubMed PMC

Kwiatkowski BA, et al. The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity. J Biol Chem. 1998;273:17525–30. PubMed

Raslova H, et al. FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia. J Clin Invest. 2004;114:77–84. PubMed PMC

Million RP, Harakawa N, Roumiantsev S, Varticovski L, Van Etten RA. A direct binding site for Grb2 contributes to transformation and leukemogenesis by the Tel-Abl (ETV6-Abl) tyrosine kinase. Mol Cell Biol. 2004;24:4685–95. PubMed PMC

Roukens MG, Alloul-Ramdhani M, Moghadasi S, Op den Brouw M, Baker DA. Downregulation of vertebrate Tel (ETV6) and Drosophila Yan is facilitated by an evolutionarily conserved mechanism of F-box-mediated ubiquitination. Mol Cell Biol. 2008;28:4394–406. PubMed PMC

Lopez RG, et al. TEL is a sequence-specific transcriptional repressor. J Biol Chem. 1999;274:30132–8. PubMed

Fenrick R, et al. TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Mol Cell Biol. 2000;20:5828–39. PubMed PMC

Machlus KR, Italiano JE., Jr The incredible journey: From megakaryocyte development to platelet formation. J Cell Biol. 2013;201:785–96. PubMed PMC

Mullighan CG, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007;446:758–64. PubMed

Strehl S, Konig M, Dworzak MN, Kalwak K, Haas OA. PAX5/ETV6 fusion defines cytogenetic entity dic(9;12)(p13;p13) Leukemia. 2003;17:1121–3. PubMed

Wu TD, Nacu S. Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics. 2010;26:873–881. PubMed PMC

McKenna A, et al. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Research. 2010;20:1297–1303. PubMed PMC

Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Research. 2010;38:e164. PubMed PMC

Liu X, Jian X, Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894–899. PubMed PMC

Rowley JW, et al. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood. 2011;118:e101–11. PubMed PMC

Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545–50. PubMed PMC

Kim D, Salzberg S. TopHat-Fusion: an algorithm for discovery of novel fusion transcripts. Genome Biology. 2011;12:R72. PubMed PMC

Ge H, et al. FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution. Bioinformatics. 2011;27:1922–1928. PubMed

Wilcox DA, et al. Induction of megakaryocytes to synthesize and store a releasable pool of human factor VIII. J Thromb Haemost. 2003;1:2477–89. PubMed

Kahr WH, et al. Abnormal megakaryocyte development and platelet function in Nbeal2(−/−) mice. Blood. 2013;122:3349–58. PubMed PMC

Urban D, et al. The VPS33B-binding protein VPS16B is required in megakaryocyte and platelet alpha-granule biogenesis. Blood. 2012;120:5032–40. PubMed PMC

Zobrazit více v PubMed

BioProject
PRJNA276621

SRA
SRP056053

dbGaP
PHS000873.V1.P1

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace